Details
Stereochemistry | ACHIRAL |
Molecular Formula | C31H37N5O3 |
Molecular Weight | 527.6572 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)(C(O)=O)C1=CN2N=C(NCCCN3CCC(CC3)OC(C4=CC=CC=C4)C5=CC=CC=C5)C=CC2=N1
InChI
InChIKey=WTBRUSNNZKWTMI-UHFFFAOYSA-N
InChI=1S/C31H37N5O3/c1-31(2,30(37)38)26-22-36-28(33-26)15-14-27(34-36)32-18-9-19-35-20-16-25(17-21-35)39-29(23-10-5-3-6-11-23)24-12-7-4-8-13-24/h3-8,10-15,22,25,29H,9,16-21H2,1-2H3,(H,32,34)(H,37,38)
Molecular Formula | C31H37N5O3 |
Molecular Weight | 527.6572 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Bamirastine (previously known as TAK 427), an antiallergic compound that inhibits ligand binding to recombinant human histamine H1 receptor. The drug was involved in phase II clinical trials for the treatment of allergic rhinitis and for patients with atopic dermatitis. However, these studies were discontinued.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: P35367 Gene ID: 3269.0 Gene Symbol: HRH1 Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/12813625 |
17.3 nM [IC50] |
PubMed
Title | Date | PubMed |
---|---|---|
Inhibition of allergic dermal inflammation by the novel imidazopyridazine derivative TAK-427 in a guinea pig experimental model of eczema. | 2002 Dec |
|
Effects of TAK-427 on acute nasal symptoms and nasal obstruction in guinea pig model of experimental allergic rhinitis. | 2003 Aug 29 |
|
Characteristics of the antihistamine effect of TAK-427, a novel imidazopyridazine derivative. | 2003 May |
|
Marked impact of P-glycoprotein on the absorption of TAK-427 in rats. | 2008 Sep |
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 18:03:12 GMT 2023
by
admin
on
Sat Dec 16 18:03:12 GMT 2023
|
Record UNII |
SIG10953FN
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C29578
Created by
admin on Sat Dec 16 18:03:13 GMT 2023 , Edited by admin on Sat Dec 16 18:03:13 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
215529-47-8
Created by
admin on Sat Dec 16 18:03:13 GMT 2023 , Edited by admin on Sat Dec 16 18:03:13 GMT 2023
|
PRIMARY | |||
|
C79560
Created by
admin on Sat Dec 16 18:03:13 GMT 2023 , Edited by admin on Sat Dec 16 18:03:13 GMT 2023
|
PRIMARY | |||
|
8463
Created by
admin on Sat Dec 16 18:03:13 GMT 2023 , Edited by admin on Sat Dec 16 18:03:13 GMT 2023
|
PRIMARY | |||
|
DTXSID60175889
Created by
admin on Sat Dec 16 18:03:13 GMT 2023 , Edited by admin on Sat Dec 16 18:03:13 GMT 2023
|
PRIMARY | |||
|
300000037010
Created by
admin on Sat Dec 16 18:03:13 GMT 2023 , Edited by admin on Sat Dec 16 18:03:13 GMT 2023
|
PRIMARY | |||
|
SIG10953FN
Created by
admin on Sat Dec 16 18:03:13 GMT 2023 , Edited by admin on Sat Dec 16 18:03:13 GMT 2023
|
PRIMARY | |||
|
CHEMBL2107732
Created by
admin on Sat Dec 16 18:03:13 GMT 2023 , Edited by admin on Sat Dec 16 18:03:13 GMT 2023
|
PRIMARY | |||
|
9806921
Created by
admin on Sat Dec 16 18:03:13 GMT 2023 , Edited by admin on Sat Dec 16 18:03:13 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> INHIBITOR |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|